QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 24, no. 1 (2005): 42-51
doi: 10.1377/hlthaff.24.1.42
© 2005 by Project HOPE
 
New Online
 * Pay Cuts For Medicare Docs
 * Access To Care Woes
 * Public Coverage More Efficient
 * Empowering Consumers
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (11)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Hlatky, M. A.
* Articles by Owens, D. K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Hlatky, M. A.
* Articles by Owens, D. K.
Related Collections
* Evidence-Based Medicine
* Health Reform
* Medicare
* Physicians
* Quality Of Care
* Research And Technology
* Politics

Case Studies

Evidence-Based Medicine And Policy: The Case Of The Implantable Cardioverter Defibrillator

Mark A. Hlatky, Gillian D. Sanders and Douglas K. Owens

The implantable cardioverter defibrillator (ICD) is a costly new treatment for patients at high risk of sudden cardiac death. Randomized trials of the ICD showed it to be effective in some groups of patients but not in others. While new trials testing the ICD were ongoing to clarify the evidence, policymakers faced immediate decisions about providing insurance coverage for the device. The high cost of ICDs, the large population of patients potentially eligible to receive them, the potential to reduce preventable deaths, and the unsettled state of the medical evidence provided a challenge to evidence-based medicine and to policymakers.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. A. Hlatky and D. B. Mark
The high cost of implantable defibrillators
Eur. Heart J., February 2, 2007; 28(4): 388 - 391.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. D. Pearson, F. G. Miller, and E. J. Emanuel
Medicare Requirement for Research Participation--Reply
JAMA, December 27, 2006; 296(24): 2924 - 2925.
[Full Text] [PDF]


Home page
CirculationHome page
D. B. Mark, C. L. Nelson, K. J. Anstrom, S. M. Al-Khatib, A. A. Tsiatis, P. A. Cowper, N. E. Clapp-Channing, L. Davidson-Ray, J. E. Poole, G. Johnson, et al.
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Circulation, July 11, 2006; 114(2): 135 - 142.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. D. Pearson and M. D. Rawlins
Quality, Innovation, and Value for Money: NICE and the British National Health Service
JAMA, November 23, 2005; 294(20): 2618 - 2622.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. D. Sanders, M. A. Hlatky, and D. K. Owens
Cost-Effectiveness of Implantable Cardioverter-Defibrillators
N. Engl. J. Med., October 6, 2005; 353(14): 1471 - 1480.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
M. S. Stanton
Implantable Cardioverter Defibrillators: An Excellent Case Study
Health Aff., January 1, 2005; 24(1): 52 - 54.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2005 Project HOPE–The People-to-People Organization
Terms and Policies